Baker et al. indicated that PARP3 is involved in TGFβ-induced EMT through the Rictor/mTORC2 signaling pathway in BRCA1-deficient triple-negative breast cancer (TNBC) cells [45]. Here, PARP3 is linked to triple-negative breast carcinoma.